Poised to Enter 2026 with Strengthened Momentum, FDA Breakthrough for a Clear Approval Pathway, and a Streamlined Path Toward Cash-Flow Breakeven ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), today announced that 2025 marked a pivotal year defined by meaningful operational progress, disciplined... Read More
